Gossamer Bio, Inc. · NASDAQ:GOSS
Invus Public Equities, L.P.'s stake in Gossamer Bio, Inc. fell to 2.80% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Invus Public Equities, L.P.'s stake in Gossamer Bio, Inc. fell to 2.80%, 6,258,880 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 2.80%
- Shares
- 6,258,880
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 2.80% | 6,258,880 |
| Invus Public Equities Advisors, LLC | 2.80% | 6,258,880 |
| Invus Global Management, LLC | 2.80% | 6,258,880 |
| Siren, L.L.C. | 2.80% | 6,258,880 |
| Avicenna Life Sci Master Fund LP | 0% | 0 |
| Avicenna Life Sci Master GP LLC | 0% | 0 |
| Ulys, L.L.C. | 0% | 0 |
| Raymond Debbane | 2.80% | 6,258,880 |
Source
Related
- Gossamer Bio, Inc.
- Invus Public Equities, L.P.
- Gossamer Bio, Inc. shareholders
- Schedule 13D/A · D. E. Shaw & Co., L.L.C. · Aug 24, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · Opaleye Management Inc. · Jul 29, 2026
- Schedule 13D/A · D. E. Shaw & Co., L.P. · Jul 24, 2026
- Schedule 13D/A · D. E. Shaw & Co., L.P. · Jul 1, 2026